300
Participants
Start Date
April 30, 2006
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Abacavir
8 mg/kg (up to 300 mg/dose) take orally twice daily
Efavirenz
200 to 600 mg taken orally once daily
Lamivudine
4 mg/kg (up to 150 mg/dose) taken orally twice daily
Lopinavir/Ritonavir
230 mg/57.5 mg/m\^2 body surface area taken orally twice daily with food
Nelfinavir
45-55 mg/kg taken orally twice daily with food
Nevirapine
120 mg/m\^2 once daily for first 14 days, tehn 200 mg/m\^2 (up to 400 mg/day) twice daily
Zidovudine
180-240 mg/m\^2 every 12 hours (up to 300 mg/dose)
Hiv-Nat Cipra Crs, Pathumwan
Bamrasnaradura Institute CIPRA CRS, Nonthaburi
Queen Savang Vadhana Memorial Hosp. CIPRA CRS, Chon Buri
Prapokklao Hosp. CIPRA CRS, Chanthaburi
Srinagarind Hosp. CIPRA CRS, Khon Kaen
Nakornping Hosp. CIPRA CRS, Chiang Mai
Chiang Rai Regional Hosp. CIPRA CRS, Muang
National Pediatric Hosp., Cambodia CIPRA CRS, Phnom Penh
Social Health Clinic, Cambodia CIPRA CRS, Phnom Penh
Comprehensive International Program of Research on AIDS
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH